PMI News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

PM

Mkt Cap

$29.7M

Volume

1.62M

Next Earnings

November 13th

Loading chart

PM

PMIPicard Medical, Inc.

PMI

Pay with—

Available Balance0.00

PM

Mkt Cap

$23.4M

Volume

1.62M

Next Earnings

November 13th

Chart Financials Earnings News About Insider Filings

Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing CompliancePicard Medical announced a 1-for-50 reverse stock split effective July 31, 2026, to maintain NYSE American listing compliance. The split was approved by stockholders on July 17, 2026. The company, parent of SynCardia Systems (maker of the FDA and Health Canada-approved total artificial heart), aims to position itself for growth while advancing its next-generation Emperor platform.GlobeNewswire Inc. · Jul 22, 2026

Kuehn Law Encourages Investors of Picard Medical Inc. to Contact Law FirmKuehn Law is investigating whether officers and directors of Picard Medical Inc. breached fiduciary duties by failing to disclose a fraudulent stock promotion scheme involving social media misinformation, coordinated share dumping by insiders through offshore accounts, and omission of risk disclosures related to artificial trading activity that inflated stock prices.GlobeNewswire Inc. · Jun 4, 2026

Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant StudiesPicard Medical announced successful completion of preclinical implant studies for its next-generation Emperor Total Artificial Heart (TAH) at University of Arizona and Banner University Medical Center. The Emperor TAH demonstrated stable hemodynamic support with an independent dual motor ventricular system designed to advance toward a fully implantable artificial heart system. Three acute implant procedures were completed with no device-related failures observed.GlobeNewswire Inc. · Jun 2, 2026

Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in TorontoPicard Medical, parent company of SynCardia Systems, announced its participation in the ISHLT 2026 Annual Meeting in Toronto. The company will present a poster on the Emperor Total Artificial Heart, a next-generation fully implantable solution for end-stage heart failure, and exhibit at booth 409 to showcase its SynCardia Total Artificial Heart technology.GlobeNewswire Inc. · Apr 16, 2026

PICARD MEDICAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Picard Medical, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action – PMIRosen Law Firm announces a securities class action lawsuit against Picard Medical, Inc. (PMI) for investors who purchased shares between September 2, 2025 and October 31, 2025. The lawsuit alleges that defendants made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, insider share dumping through offshore accounts, and artificial trading activity that inflated stock prices. The lead plaintiff deadline is April 13, 2026.GlobeNewswire Inc. · Apr 9, 2026

ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRXRosen Law Firm has filed securities class action lawsuits against ImmunityBio, Inc., Franklin BSP Realty Trust, Inc., and Picard Medical, Inc. The firm is seeking lead plaintiffs and encouraging investors who purchased securities during specified class periods to join the litigation. The ImmunityBio lawsuit alleges that defendants made false statements about the company's business and overstated capabilities of Anktiva.GlobeNewswire Inc. · Apr 7, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Picard Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PMIRosen Law Firm is urging investors who purchased Picard Medical, Inc. (PMI) securities between September 2, 2025 and October 31, 2025 to join a class action lawsuit. The lawsuit alleges that Picard Medical made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, insider share dumping through offshore accounts, and artificial trading activity that inflated stock prices. The lead plaintiff deadline is April 13, 2026.GlobeNewswire Inc. · Apr 7, 2026

ROSEN, HIGHLY RANKED INVESTOR RIGHTS COUNSEL, Encourages Picard Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– PMIRosen Law Firm is urging investors who purchased Picard Medical, Inc. (PMI) securities between September 2, 2025 and October 31, 2025 to join a class action lawsuit. The lawsuit alleges that Picard made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, insider share dumping through offshore accounts, and artificial trading activity that inflated stock prices. The lead plaintiff deadline is April 13, 2026.GlobeNewswire Inc. · Apr 3, 2026

Bronstein, Gewirtz & Grossman LLC Urges Picard Medical, Inc. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Picard Medical, Inc. (NYSE: PMI) alleging securities fraud involving false stock promotion schemes, coordinated share dumping by insiders using offshore accounts, and omitted risk disclosures. The lawsuit covers investors who purchased PMI securities between September 2, 2025 and October 31, 2025, with a lead plaintiff deadline of April 3, 2026.GlobeNewswire Inc. · Mar 30, 2026

ROSEN, A LEADING RIGHTS LAW FIRM, Encourages Picard Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PMIRosen Law Firm is encouraging investors who purchased Picard Medical, Inc. (PMI) securities between September 2, 2025 and October 31, 2025 to join a class action lawsuit. The lawsuit alleges that defendants made materially false statements and failed to disclose that Picard was subject to a fraudulent stock promotion scheme involving social media misinformation, insider share dumping through offshore accounts, and artificial trading activity that inflated stock prices. The lead plaintiff deadline is April 13, 2026.GlobeNewswire Inc. · Mar 27, 2026

to start trading

PM

PMIPicard Medical, Inc.

PMI

Pay with—

Available Balance0.00

Your PositionYou don't own any PMI yet.

Related Tickers

Earnings